Pathfinders in Biopharma

Website Traffic Reveals Biopharma Sales Trends


Listen Later

A new RBC ElementsTM report, “Insights from the BioWeb,” looks at the predictive potential of website traffic as a means to uncover underappreciated market trends and sales insights. Mark Odendahl, Head of US Capital Markets Research, is joined by Brian Abrahams, Head of Biotechnology at RBC Capital Markets, to discuss the report’s findings. 

...more
View all episodesView all episodes
Download on the App Store

Pathfinders in BiopharmaBy RBC Capital Markets

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Pathfinders in Biopharma

View all
Motley Fool Money by The Motley Fool

Motley Fool Money

3,241 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,724 Listeners

Exchanges by Goldman Sachs

Exchanges

971 Listeners

Odd Lots by Bloomberg

Odd Lots

1,999 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,661 Listeners

The a16z Show by Andreessen Horowitz

The a16z Show

1,098 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

339 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,051 Listeners

Thoughts on the Market by Morgan Stanley

Thoughts on the Market

1,304 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,109 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

35 Listeners

RBC's Markets in Motion by RBC Capital Markets

RBC's Markets in Motion

41 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

19 Listeners

Industries in Motion by RBC Capital Markets

Industries in Motion

10 Listeners

Powering Sustainable Ideas by RBC Capital Markets

Powering Sustainable Ideas

0 Listeners

The Markets by Goldman Sachs

The Markets

77 Listeners

Strategic Alternatives by RBC Capital Markets

Strategic Alternatives

18 Listeners

The Top Line by Fierce Life Sciences

The Top Line

16 Listeners

Macro Minutes by RBC Capital Markets

Macro Minutes

3 Listeners